CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- 4 Open-market buy Chief Executive Officer bought 20,000 shares at $4.07 ($81,400)
- 4 Shares withheld for taxes SVP, General Counsel gave up 563 shares (to pay taxes)
- 4 Open-market sale Director sold 327 shares at $3.90 ($1,275)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at an average $3.82 ($11,458)
- 4 Open-market buy SVP, General Counsel bought 3,000 shares at $3.80 ($11,400)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Shares withheld for taxes Chief Financial Officer gave up 1,187 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 4 Open-market sale Director sold 338 shares at $4.45 ($1,504)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
- 4 Grant or award Director acquired 58,689 shares (grant or award)
Page 16 of 66 · 1,318 filings